Medica 2021 Stand D24 Hall 12
Corsano Health is launching its CardioWatch 287 at MEDICA 2021.
Corsano’s CardioWatch 287 accuracy of a state-of-the-art bracelet has been validated in six third party clinical investigations. The independent validations of Corsano Health’s CardioWatch 287 is important evidence to prove accurate measurement of five vital parameters. Moreover, Corsano offers access to raw PPG and ACC data for further analysis to academic researchers and contract research organizations. Corsano’s non-invasive ergonomic wearables deliver medically validate data with superior patient compliance. Additionally, patient satisfaction surveys conducted at the closure of the studies cite convenience and ease to use of the CardioWatch 287 devices.
Please visit us at Stand D24 Hall 12.
We are happy to announce that Corsano Health B.V. is medically certified complying with Annex IX (MDR) and EN-ISO 13485 standards.
Accuracy of heartbeat detection
Elsevier’s Journal of Electrocardiology just published a validation study that showed that the Corsano 287 CardioWatch/Bracelet with PPG-technology can determine HR and RR-intervals with high accuracy in a cardiovascular patient population, with high quality output in different subgroups, especially when combined with a signal quality indicator.
Corsano CardioWatch is a wrist worn medical grade multi sensor bracelet to capture vital parameters. Primary use cases are 24/7 continuous clinical trials and remote patient monitoring. See the movie here to learn more about the capabilities of our bracelet, the technology and the efficient ways to retrieve data.
CardioWatch 287-1 is in the final stages to be CE medically certified and we have started the process for FDA Clearance. Bracelets are now available as investigative device.
AFNET Clinical Trial
Corsano shipped 2000 CardioWatches 287-1 as Investigative Devices for the AFNET 9 study. The Smart in OAC – AFNET 9 study is testing whether unknown atrial fibrillation (AF) can be detected via an app and a monitoring bracelet. It is the objective to detect AF at an early stage using modern technologies. The number of newly detected, previously unknown episodes of atrial fibrillation and the effectivity of the program will be evaluated.
Corsano Trials iOS and Android Applications are now available in Beta! We ship CardioWatch 287-1 as an Investigative Device and accept orders for our Evaluation Package.
Corsano CardioWatch is a wrist worn medical grade multi sensor bracelet to capture up to 8 vital parameters. Primary use cases are 24/7 continuous clinical trials and remote patient monitoring.
Researchers can set vital parameters and the sample frequency from the Settings Menu. Date is saved to Corsano’s Health Cloud and available for easy download in CSV, JSON and PDF format. Alternatively, data can be accesed via our API.
The silicon strap of the Corsano CardioWatch Bracelet has a rescessed area to attach a sticker with Patient information. We are also in discussion with hospitals to add RFID identification
Corsano CardioWatch Bracelets have an ergonomic design to stimulate 24/7 continous wear, particularly important for Hospital-to-Home Use Cases
We have started to assemble 5000 units of the Corsano CardioWatch Bracelet, to be used in various Clinical and Implementation Trials
Latest versions of the Corsano CardioWatch Bracelet have an easy to use magnetic charger solution with green and orange LEDs to indicate charging and pairing status
Corsano is studying various silicon straps, including 3M Coated Tissue Tape to attach patient information.
The first 3D printed Corsano Bracelet were received.
Corsano’s Bracelet has been developed with state of the art CAD-CAM software.
Initial design was created in closed discussion with physicians and stakeholders.